Mesalamine
NDC 84612-175, Mesalamine, tablet, delayed release, from Nuvaila Limited.
- Product NDC
- 84612-175
- Status
- Listed
- Labeler
- Nuvaila Limited
- Dosage form
- TABLET, DELAYED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA211858
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/84612-175 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MESALAMINE1.2 g/1
Pharmacologic classes
Aminosalicylate [EPC]; Aminosalicylic Acids [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 84612-175-13 | 84612017513 | 120 TABLET, DELAYED RELEASE in 1 BOTTLE (84612-175-13) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/875d573f-99a1-426a-8321-4d511690d503
Use it
Look up 84612-175 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/84612-175 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 84612-175. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.